Inventor · disambiguated record
Jacques F. Banchereau
Also filed as: BANCHEREAU JACQUES · BANCHEREAU JACQUES F
56 granted patents·72 pending applications·879 citations·filing 1989–2024
99Inventor score
Files withBAYLOR RES INST48BAYLOR RES INSTITUTE15BANCHEREAU JACQUES F9SCHERING CORP9ZURAWSKI GERARD8
Top patents by PatentIndex Score
128 records- 0197US9234040B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsBAYLOR RES INST·Filed 2013·Granted Jan 12, 2016·26 cites·13 claims
- 0297US9102730B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsBAYLOR RES INST·Filed 2013·Granted Aug 11, 2015·25 cites·8 claims
- 0397US8728481B2Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)BANCHEREAU JACQUES F·Filed 2012·Granted May 20, 2014·30 cites·9 claims
- 0497US8518410B2Fusion protein with HIV antigenZURAWSKI GERARD·Filed 2010·Granted Aug 27, 2013·50 cites·22 claims
- 0597US8449888B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsZURAWSKI GERARD·Filed 2011·Granted May 28, 2013·35 cites·8 claims
- 0697US8236934B2Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)BANCHEREAU JACQUES F·Filed 2008·Granted Aug 7, 2012·36 cites·44 claims
- 0796US8961991B2Anti-CD40 targeted fusion proteinsZURAWSKI GERARD·Filed 2010·Granted Feb 24, 2015·48 cites·18 claims
- 0895US9416186B2Antigen presenting cell targeted anti-viral vaccinesZURAWSKI GERARD·Filed 2013·Granted Aug 16, 2016·27 cites·9 claims
- 0995US9102734B2Fusion proteins comprising antibody and HPV E6 and E7 antigensZURAWSKI GERARD·Filed 2010·Granted Aug 11, 2015·46 cites·13 claims
- 1095US8586052B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsZURAWSKI GERARD·Filed 2012·Granted Nov 19, 2013·27 cites·10 claims
- 1193US12016915B2Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)BAYLOR RES INSTITUTE·Filed 2021·Granted Jun 25, 2024·1 cites·7 claims
- 1293US11806390B2Fusion proteins comprising an anti-CD40 antibody and cancer antigensBAYLOR RES INSTITUTE·Filed 2021·Granted Nov 7, 2023·2 cites·14 claims
- 1392US5959085AHuman monoclonal antibodies against human cytokines and methods of making and using such antibodiesSCHERING CORP·Filed 1994·Granted Sep 28, 1999·139 cites·8 claims
- 1491US11267895B2Nucleic acids encoding anti-CD40 antibodiesBAYLOR RES INSTITUTE·Filed 2020·Granted Mar 8, 2022·2 cites·13 claims
- 1591US2025018025A1Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc-asgpr)BAYLOR RES INSTITUTE·Filed 2024·Application pending·0 cites
- 1690US9562104B2Anti-CD40 antibodiesBANCHEREAU JACQUES F·Filed 2010·Granted Feb 7, 2017·10 cites·20 claims
- 1790US9109011B2Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/NefBANCHEREAU JACQUES F·Filed 2009·Granted Aug 18, 2015·27 cites·5 claims
- 1890US8057798B2Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cellsZURAWSKI GERALD·Filed 2008·Granted Nov 15, 2011·30 cites·5 claims
- 1988US10683361B2Anti-CD40 antibodiesBAYLOR RES INSTITUTE·Filed 2018·Granted Jun 16, 2020·2 cites·15 claims
- 2088US6274711B1Purified mammalian CTLA-8 antigens and related reagentsINST NAT SANTE RECH MED·Filed 1995·Granted Aug 14, 2001·84 cites·7 claims
- 2187US9339556B2Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1)BAYLOR RES INST·Filed 2013·Granted May 17, 2016·8 cites·13 claims
- 2287US7608395B2Systemic lupus erythematosus diagnostic assayBAYLOR RES INST·Filed 2005·Granted Oct 27, 2009·13 cites·15 claims
- 2386US8481314B2Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized LDL receptor-1 (LOX-1)BANCHEREAU JACQUES F·Filed 2008·Granted Jul 9, 2013·8 cites·8 claims
- 2486US7879980B2Monoclonal antibodies to human CTLA-8 (IL-17A)SCHERING CORP·Filed 2007·Granted Feb 1, 2011·6 cites·16 claims
- 2586US7622110B2Compositions and methods for the systemic treatment of arthritisBAYLOR RES INST·Filed 2007·Granted Nov 24, 2009·5 cites·3 claims
- 2685US10988544B2Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptidesBAYLOR RES INSTITUTE·Filed 2017·Granted Apr 27, 2021·1 cites·11 claims
- 2785US6706870B2Nucleic acids encoding CTLA-8; and related reagentsINST NAT SANTE RECH MED·Filed 2001·Granted Mar 16, 2004·9 cites·17 claims
- 2884US9862927B2Dendritic cell vaccinesBANCHEREAU JACQUES F·Filed 2011·Granted Jan 9, 2018·7 cites·13 claims
- 2984US7888481B2Anti-interferon alpha monoclonal antibodies and methods for useBAYLOR RES INST·Filed 2009·Granted Feb 15, 2011·9 cites·14 claims
- 3084US2023134568A1Compositions and Methods for the Systemic Treatment of ArthritisBAYLOR RES INSTITUTE·Filed 2022·Application pending·0 cites
- 3183US10087256B2Method of making an anti-CD40 antibodyBAYLOR RES INSTITUTE·Filed 2017·Granted Oct 2, 2018·2 cites·11 claims
- 3283US9315580B2Vaccines directed to langerhans cellsBAYLOR RES INST·Filed 2013·Granted Apr 19, 2016·5 cites·7 claims
- 3383US8148346B2Compositions and methods for the systemic treatment of arthritisBANCHEREAU JACQUES·Filed 2009·Granted Apr 3, 2012·4 cites·5 claims
- 3481US6004807AIn vitro generation of human dendritic cellsSCHERING CORP·Filed 1996·Granted Dec 21, 1999·59 cites·6 claims
- 3580US10980869B2Fusion proteins comprising an anti-CD40 antibody and cancer antigensBAYLOR RES INSTITUTE·Filed 2017·Granted Apr 20, 2021·1 cites·7 claims
- 3680US9567401B2Anti-CD40 antibodiesBAYLOR RES INST·Filed 2014·Granted Feb 14, 2017·2 cites·9 claims
- 3779US9885017B2Compositions and methods to immunize against hepatitis C virusBAYLOR RES INSTITUTE·Filed 2014·Granted Feb 6, 2018·3 cites·14 claims
- 3878US2022340670A1Anti-cd40 antibodies and uses thereofBAYLOR RES INSTITUTE·Filed 2022·Application pending·0 cites
- 3977US7544357B2Methods for treating autoimmune diseases in a subject and in vitro diagnostic assaysBAYLOR RES INST·Filed 2002·Granted Jun 9, 2009·11 cites·6 claims
- 4076US9045542B2Controlling allergy and asthma by activating human DCs via Dectin-1 or toll-like receptor 2 (TLR2)OH SANGKON·Filed 2012·Granted Jun 2, 2015·6 cites·4 claims
- 4176US8221748B2Compositions and methods for the systemic treatment of arthritisBANCHEREAU JACQUES·Filed 2009·Granted Jul 17, 2012·1 cites·3 claims
- 4276US7615212B2Compositions and methods for the systemic treatment of arthritisBAYLOR RES INST·Filed 2005·Granted Nov 10, 2009·1 cites·4 claims
- 4376US6319493B1Treatment of neoplastic disease with interleukin-10SCHERING CORP·Filed 2000·Granted Nov 20, 2001·3 cites·14 claims
- 4475US11406688B2Compositions and methods for the systemic treatment of arthritisBAYLOR RES INSTITUTE·Filed 2020·Granted Aug 9, 2022·0 cites·7 claims
- 4575US2021221904A1Fusion proteins comprising an anti-cd40 antibody and hiv antigenic peptidesBAYLOR RES INSTITUTE·Filed 2021·Application pending·0 cites
- 4673US9061066B2Immunoadjuvant compounds and uses thereofGORVEL JEAN-PIERRE·Filed 2011·Granted Jun 23, 2015·2 cites·8 claims
- 4772US2008112962A1Dendritic Cells Loaded with Heat Shocked Melanoma Cell BodiesBAYLOR RES INST·Filed 2007·Application pending·0 cites
- 4872US2008286314A1Dendritic cells loaded with heat shocked melanoma cell bodiesBAYLOR RES INST·Filed 2007·Application pending·0 cites
- 4972US2008112924A1Dendritic Cells Loaded with Heat Shocked Melanoma Cell BodiesBAYLOR RES INST·Filed 2007·Application pending·0 cites
- 5069US2014179807A1Module-level analysis of peripheral blood leukocyte transcriptional profilesCHAUSSABEL DAMIEN·Filed 2013·Application pending·0 cites
Showing the top 50 of 128 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jacques F. Banchereau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →